Dale W. Garsed

21.3k total citations · 1 hit paper
12 papers, 397 citations indexed

About

Dale W. Garsed is a scholar working on Molecular Biology, Reproductive Medicine and Oncology. According to data from OpenAlex, Dale W. Garsed has authored 12 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Reproductive Medicine and 6 papers in Oncology. Recurrent topics in Dale W. Garsed's work include Ovarian cancer diagnosis and treatment (7 papers), PARP inhibition in cancer therapy (5 papers) and DNA Repair Mechanisms (3 papers). Dale W. Garsed is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), PARP inhibition in cancer therapy (5 papers) and DNA Repair Mechanisms (3 papers). Dale W. Garsed collaborates with scholars based in Australia, United States and Switzerland. Dale W. Garsed's co-authors include David D.L. Bowtell, Rowan Miller, David K. Chang, Sohrab P. Shah, Jonathan A. Ledermann, Alexandra Léary, Clare L. Scott, Xavier Matías‐Guiu, Lucy Yates and Violeta Serra and has published in prestigious journals such as Journal of Clinical Investigation, Nature reviews. Cancer and Cochrane Database of Systematic Reviews.

In The Last Decade

Dale W. Garsed

10 papers receiving 390 citations

Hit Papers

ESMO recommendations on predictive biomarker testing for ... 2020 2026 2022 2024 2020 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer
    2020 261 citations Rowan Miller, Alexandra Léary et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dale W. Garsed Australia 7 257 195 127 68 67 12 397
Marie K. Classon Canada 2 238 0.9× 295 1.5× 54 0.4× 93 1.4× 36 0.5× 2 401
Khyati Meghani United States 9 285 1.1× 482 2.5× 45 0.4× 132 1.9× 40 0.6× 17 646
Dana‐Adriana Botesteanu United States 6 304 1.2× 167 0.9× 117 0.9× 47 0.7× 30 0.4× 9 411
Carolynn E. Ohlson United States 5 353 1.4× 355 1.8× 68 0.5× 77 1.1× 37 0.6× 6 640
Christopher Taylor United States 3 179 0.7× 156 0.8× 131 1.0× 58 0.9× 69 1.0× 6 494
Giulia Scotto Italy 10 242 0.9× 177 0.9× 83 0.7× 99 1.5× 37 0.6× 19 458
Irene Ekwede United States 9 273 1.1× 139 0.7× 68 0.5× 26 0.4× 19 0.3× 25 360
Wa Zhang United States 13 192 0.7× 454 2.3× 80 0.6× 130 1.9× 69 1.0× 15 668
Shamima Yeasmin Japan 10 115 0.4× 289 1.5× 94 0.7× 123 1.8× 26 0.4× 19 442
Fanling Meng China 15 118 0.5× 444 2.3× 55 0.4× 154 2.3× 23 0.3× 34 599

Countries citing papers authored by Dale W. Garsed

Since Specialization
Citations

This map shows the geographic impact of Dale W. Garsed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dale W. Garsed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dale W. Garsed more than expected).

Fields of papers citing papers by Dale W. Garsed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dale W. Garsed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dale W. Garsed. The network helps show where Dale W. Garsed may publish in the future.

Co-authorship network of co-authors of Dale W. Garsed

This figure shows the co-authorship network connecting the top 25 collaborators of Dale W. Garsed. A scholar is included among the top collaborators of Dale W. Garsed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dale W. Garsed. Dale W. Garsed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Petousis, Stamatios, İlker Kahramanoğlu, Christian Appenzeller‐Herzog, et al.. (2025). PARP Inhibitor Maintenance After First-Line Chemotherapy in Advanced-Stage Epithelial Ovarian Cancer. JAMA Network Open. 8(11). e2541648–e2541648.
2.
Garsed, Dale W., et al.. (2024). Homologous recombination proficient subtypes of high-grade serous ovarian cancer: treatment options for a poor prognosis group. Frontiers in Oncology. 14. 1387281–1387281. 2 indexed citations
3.
Ewald, Hannah, Christian Appenzeller‐Herzog, Nicolò Bizzarri, et al.. (2024). Predictive value of homologous recombination deficiency status for survival outcomes in primary tubo-ovarian high-grade serous carcinoma. Cochrane Database of Systematic Reviews. 2024(9). CD015896–CD015896.
4.
5.
6.
Miller, Rowan, Florian Laforêts, Panoraia Kotantaki, et al.. (2022). The Tumor Microenvironment of Clear-Cell Ovarian Cancer. Cancer Immunology Research. 10(11). 1326–1339. 21 indexed citations
7.
Miller, Rowan, Alexandra Léary, Clare L. Scott, et al.. (2020). ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer. Annals of Oncology. 31(12). 1606–1622. 261 indexed citations breakdown →
8.
Herschtal, Alan, Brad H. Nelson, Anna DeFazio, et al.. (2019). Going to extremes: determinants of extraordinary response and survival in patients with cancer. Nature reviews. Cancer. 19(6). 339–348. 24 indexed citations
9.
Natanzon, Yanina, Madalene A. Earp, Julie M. Cunningham, et al.. (2018). Genomic Analysis Using Regularized Regression in High-Grade Serous Ovarian Cancer. Cancer Informatics. 17. 2410501645–2410501645. 6 indexed citations
10.
Kansara, Maya, Huei San Leong, Puiyi Pang, et al.. (2013). Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation. Journal of Clinical Investigation. 123(12). 5351–5360. 64 indexed citations
11.
Pédeutour, Florence, Georges Maire, David M. Thomas, et al.. (2012). A newly characterized human well-differentiated liposarcoma cell line contains amplifications of the 12q12-21 and 10p11-14 regions. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 461(1). 67–78. 9 indexed citations
12.
Garsed, Dale W., Andrew J. Holloway, & David M. Thomas. (2009). Cancer‐associated neochromosomes: a novel mechanism of oncogenesis. BioEssays. 31(11). 1191–1200. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie K. Classon Breakdown of academic impact, for papers by Khyati Meghani Breakdown of academic impact, for papers by Dana‐Adriana Botesteanu Breakdown of academic impact, for papers by Carolynn E. Ohlson Breakdown of academic impact, for papers by Christopher Taylor Breakdown of academic impact, for papers by Giulia Scotto Breakdown of academic impact, for papers by Irene Ekwede Breakdown of academic impact, for papers by Wa Zhang Breakdown of academic impact, for papers by Shamima Yeasmin Breakdown of academic impact, for papers by Fanling Meng
Rankless by CCL
2026